Inactive Instrument
Pressure BioSciences, Inc. Share Price Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 125K 118K 107K 201K 13.75M 202K 1.41M 544K 6.98M 538K 527K 22.37M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20M 18.93M 17.18M 32.1M 2.2B 32.26M 225M 87.07M 1.12B 86.18M 84.28M 3.58B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 15/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 02/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 23/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 31/12/1991 | |
Jeffrey Peterson
CHM | Chairman | 70 | 07/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 07/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.53% | +8.69% | +36.94% | +27.70% | 240B | ||
| +1.99% | +3.73% | +11.57% | -16.75% | 146B | ||
| +0.33% | +8.58% | -11.73% | +29.78% | 135B | ||
| -0.82% | -3.14% | -56.00% | -17.67% | 63.64B | ||
| +0.16% | -0.70% | -19.34% | -16.71% | 49.27B | ||
| -1.15% | +2.40% | +17.53% | +20.56% | 51.46B | ||
| +1.72% | +8.01% | +22.92% | +34.88% | 43.33B | ||
| +2.65% | +6.15% | +41.78% | +55.81% | 41.13B | ||
| +7.10% | +19.60% | +141.60% | +67.76% | 34.57B | ||
| Average | +1.51% | +3.16% | +20.59% | +20.59% | 89.41B | |
| Weighted average by Cap. | +1.29% | +4.32% | +16.10% | +16.74% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.51M 1.43M 1.29M 2.42M 166M 2.43M 16.98M 6.56M 84.14M 6.49M 6.35M 270M | 1.98M 1.72M 1.63M 1.48M 2.77M 190M 2.78M 19.41M 7.5M 96.22M 7.43M 7.26M 309M |
| Net income | -16.08M -14.01M -13.26M -12.03M -22.49M -1.54B -22.6M -158M -61M -782M -60.37M -59.04M -2.51B | -29.31M -25.54M -24.18M -21.94M -41.01M -2.81B -41.21M -288M -111M -1.43B -110M -108M -4.57B |
| Net Debt | 20.53M 17.89M 16.93M 15.36M 28.71M 1.97B 28.86M 201M 77.88M 999M 77.08M 75.38M 3.2B | 22.8M 19.87M 18.81M 17.07M 31.9M 2.19B 32.06M 224M 86.53M 1.11B 85.64M 83.75M 3.56B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















